Correia Penélope, Spínola Ana, Correia Joana F, Pereira Ana Marta, Nora Mário
General Surgery, Centro Hospitalar de Entre Douro e Vouga, Santa Maria da Feira, PRT.
Immunohemotherapy, Centro Hospitalar de Entre Douro e Vouga, Santa Maria da Feira, PRT.
Cureus. 2023 Jan 25;15(1):e34205. doi: 10.7759/cureus.34205. eCollection 2023 Jan.
Upper gastrointestinal bleeding (UGB) is a common emergency and a major cause of morbidity and mortality worldwide. An early and accurate assessment at admission is essential to estimate the severity of each case, assisting in the management of patients. The Glasgow-Blatchford score (GBS) is currently recommended for risk stratification of UGB in the emergency department (ED), helping triage patients to in-hospital vs. ambulatory management. The aim of this study was to test the validity of the GBS in an ED.
Patients who presented to the ED with a diagnosis of UGB between 2017 and 2018 were retrospectively analyzed.
The mean GBS value of the 149 patients included in the study was 10.3. Of the patients, 4.3% had values ≤1 and 8.7% had values ≤3. The sensitivity and negative predictive value for intervention needs (98.9% and 91.7%) and complications in 30 days (100% and 100%) remained high with a threshold ≤3. In the receiver operating characteristic curves, GBS presented an area under the curve of 0.883 and 0.625, regarding the need for intervention and complications in 30 days, respectively.
In our population, the threshold ≤2, and eventually ≤3, allows the identification of twice as many low-risk patients, manageable as outpatients, without significant increases in intervention needs or complications in 30 days.
上消化道出血(UGB)是一种常见的急症,也是全球发病和死亡的主要原因。入院时进行早期准确评估对于估计每个病例的严重程度至关重要,有助于患者的管理。目前推荐使用格拉斯哥-布拉奇福德评分(GBS)对急诊科(ED)的UGB进行风险分层,帮助将患者分流至住院治疗或门诊治疗。本研究的目的是在急诊科检验GBS的有效性。
对2017年至2018年间因UGB诊断而就诊于急诊科的患者进行回顾性分析。
纳入研究的149例患者的平均GBS值为10.3。其中,4.3%的患者评分≤1,8.7%的患者评分≤3。当阈值≤3时,干预需求(98.9%和91.7%)和30天内并发症(100%和100%)的敏感性和阴性预测值仍然很高。在受试者工作特征曲线中,GBS在30天内干预需求和并发症方面的曲线下面积分别为0.883和0.625。
在我们的研究人群中,阈值≤2,最终≤3,能够识别出低风险患者数量增加一倍,这些患者可作为门诊患者进行管理,且30天内干预需求或并发症无显著增加。